Skip to content

Fusion Status After ACDF

Fusion Status of Machined Allograft Versus Iliac Crest Allograft in Anterior Cervical Discectomy and Fusion: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05986006
Enrollment
124
Registered
2023-08-14
Start date
2023-08-07
Completion date
2024-08-31
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine Fusion, Spine Surgery

Brief summary

Pseudarthrosis, a failure of bony fusion, is one of the most common causes of revision surgery following anterior cervical discectomy and fusion (ACDF). The interbody spacer is an important component of bony fusion in ACDF, and we aim to compare machined allograft spacers versus iliac crest allograft in a randomized controlled trial.

Detailed description

Pseudarthrosis, a failure of bony fusion, is one of the most common causes of revision surgery following anterior cervical discectomy and fusion (ACDF). The interbody spacer is an important component of bony fusion in ACDF, and we aim to compare machined allograft spacers versus iliac crest allograft in a randomized controlled trial. We hypothesize that iliac crest allograft will improve anterior cervical discectomy and fusion arthrodesis rates and diminish the amount of intervertebral graft resorption when compared to off-the-shelf machined allografts

Interventions

PROCEDUREAnterior Cervical Disc Fusion (ACDF) Surgery w/ machined bone allograft

Participant will undergo primary, elective one-level to four-level ACDF using machined bone allograft

PROCEDUREAnterior Cervical Disc Fusion (ACDF) Surgery w/ Iliac Crest Bone Graft

Participant will undergo primary, elective one-level to four-level ACDF using iliac crest bone allograft

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients 18 years of age or older * preoperative diagnosis of cervical radiculopathy and/or cervical myelopathy.

Exclusion criteria

* patients undergoing a revision cervical procedure * current smokers * patient with surgical indications of tumor, infection, or trauma

Design outcomes

Primary

MeasureTime frameDescription
Improved participant reported outcome measures (PROMs)-12 yearsInvestigators will ask participants to complete the Short Form-12 survey (SF-12) at 3 months, 6 months, 12 months, and 24 months following surgery
Improved participant reported outcome measures (PROMs)-22 yearsInvestigators will ask participants to complete the Visual Analog Score (VAS) for Neck and Arm, Neck Disability Index (NDI), at 3 months, 6 months, 12 months, and 24 months following surgery
Improved participant reported outcome measures (PROMs)-32 yearsInvestigators will ask participants to complete the modified Japanese Orthopaedic Association (mJOA) score) at 3 months, 6 months, 12 months, and 24 months following surgery
Fusion status after surgery2 yearsFusion status will be assessed using Postoperative x-rays (AP, lateral, flexion, extension) which will be taken at 3 months, 6 months, 12 months, and 24 months following surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026